Radionuclide-labeled nanostructures for In Vivo imaging of cancer
Open Access
- 13 May 2015
- journal article
- Published by Springer Nature in Nano Convergence
- Vol. 2 (1)
Abstract
Molecular imaging plays an important role in the non-invasive diagnosis and the guiding or monitoring of disease treatment. Different imaging modalities have been developed, and each method possesses unique strengths. While a variety of molecules have been used previously in nuclear imaging, the exceptional properties of nanostructures in recent research enable the deployment of accurate and efficient diagnostic agents using radionuclide-nanostructures. This review focuses on the radionuclide labeling strategies of various nanostructures and their applications for multimodality tumor imaging.Keywords
This publication has 87 references indexed in Scilit:
- In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-grapheneBiomaterials, 2012
- Molecular imaging: current status and emerging strategiesClinical Radiology, 2010
- Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?Journal of Nanoparticle Research, 2010
- PET/NIRF/MRI triple functional iron oxide nanoparticlesBiomaterials, 2010
- Molecular imaging and therapy of cancer with radiolabeled nanoparticlesNano Today, 2009
- Molecular imaging with single-walled carbon nanotubesNano Today, 2009
- Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted miceBiomaterials, 2009
- Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living MiceSmall, 2009
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- Are quantum dots ready for in vivo imaging in human subjects?Discover Nano, 2007